Catalent is continuing to expand its fast-growing biologics operations, agreeing to acquire Bristol-Myers Squibb (BMS)’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy, for an undisclosed price.
{iframe}https://www.genengnews.com/news/catalent-acquires-bms-manufacturing-plant-in-italy-expanding-biologics-operations/?utm_medium=newsletter&utm_source=GEN%20Daily%20News%20Highlights&utm_content=01&utm_campaign=GEN%20Daily%20News%20Highlights_20190620&oly_enc_id=1673D8247356B7U{/iframe}